nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—Abdominal distress—Metformin—polycystic ovary syndrome	0.132	0.175	CcSEcCtD
Alprazolam—Brotizolam—PTAFR—polycystic ovary syndrome	0.0698	0.947	CrCbGaD
Alprazolam—Gastrointestinal symptom NOS—Metformin—polycystic ovary syndrome	0.0303	0.0403	CcSEcCtD
Alprazolam—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.022	0.0292	CcSEcCtD
Alprazolam—Rigors—Metformin—polycystic ovary syndrome	0.0218	0.029	CcSEcCtD
Alprazolam—Chest discomfort—Metformin—polycystic ovary syndrome	0.0201	0.0268	CcSEcCtD
Alprazolam—Lightheadedness—Metformin—polycystic ovary syndrome	0.0159	0.0212	CcSEcCtD
Alprazolam—Ear pain—Metformin—polycystic ovary syndrome	0.0151	0.0202	CcSEcCtD
Alprazolam—Nasal congestion—Metformin—polycystic ovary syndrome	0.0142	0.0189	CcSEcCtD
Alprazolam—Lethargy—Metformin—polycystic ovary syndrome	0.0132	0.0175	CcSEcCtD
Alprazolam—Pain in extremity—Metformin—polycystic ovary syndrome	0.0129	0.0172	CcSEcCtD
Alprazolam—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.0119	0.0159	CcSEcCtD
Alprazolam—Breast disorder—Metformin—polycystic ovary syndrome	0.0117	0.0155	CcSEcCtD
Alprazolam—Cramp muscle—Metformin—polycystic ovary syndrome	0.0116	0.0155	CcSEcCtD
Alprazolam—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.0116	0.0154	CcSEcCtD
Alprazolam—Influenza—Metformin—polycystic ovary syndrome	0.0112	0.0149	CcSEcCtD
Alprazolam—Sweating increased—Metformin—polycystic ovary syndrome	0.0109	0.0145	CcSEcCtD
Alprazolam—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.0107	0.0142	CcSEcCtD
Alprazolam—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.0104	0.0138	CcSEcCtD
Alprazolam—Infestation NOS—Metformin—polycystic ovary syndrome	0.00996	0.0133	CcSEcCtD
Alprazolam—Infestation—Metformin—polycystic ovary syndrome	0.00996	0.0133	CcSEcCtD
Alprazolam—Drowsiness—Metformin—polycystic ovary syndrome	0.00996	0.0133	CcSEcCtD
Alprazolam—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00942	0.0125	CcSEcCtD
Alprazolam—Hepatitis—Metformin—polycystic ovary syndrome	0.00894	0.0119	CcSEcCtD
Alprazolam—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00889	0.0118	CcSEcCtD
Alprazolam—Oedema peripheral—Metformin—polycystic ovary syndrome	0.0088	0.0117	CcSEcCtD
Alprazolam—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00878	0.0117	CcSEcCtD
Alprazolam—Eye disorder—Metformin—polycystic ovary syndrome	0.00835	0.0111	CcSEcCtD
Alprazolam—Cardiac disorder—Metformin—polycystic ovary syndrome	0.0083	0.011	CcSEcCtD
Alprazolam—Angiopathy—Metformin—polycystic ovary syndrome	0.00811	0.0108	CcSEcCtD
Alprazolam—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00806	0.0107	CcSEcCtD
Alprazolam—Chills—Metformin—polycystic ovary syndrome	0.00802	0.0107	CcSEcCtD
Alprazolam—Malnutrition—Metformin—polycystic ovary syndrome	0.00778	0.0104	CcSEcCtD
Alprazolam—Muscle spasms—Metformin—polycystic ovary syndrome	0.00748	0.00996	CcSEcCtD
Alprazolam—Vision blurred—Metformin—polycystic ovary syndrome	0.00733	0.00976	CcSEcCtD
Alprazolam—Tremor—Metformin—polycystic ovary syndrome	0.00729	0.0097	CcSEcCtD
Alprazolam—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00722	0.00961	CcSEcCtD
Alprazolam—Malaise—Metformin—polycystic ovary syndrome	0.00702	0.00934	CcSEcCtD
Alprazolam—Syncope—Metformin—polycystic ovary syndrome	0.00698	0.00929	CcSEcCtD
Alprazolam—Palpitations—Metformin—polycystic ovary syndrome	0.00688	0.00915	CcSEcCtD
Alprazolam—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00684	0.0091	CcSEcCtD
Alprazolam—Chest pain—Metformin—polycystic ovary syndrome	0.00662	0.00882	CcSEcCtD
Alprazolam—Myalgia—Metformin—polycystic ovary syndrome	0.00662	0.00882	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00658	0.00876	CcSEcCtD
Alprazolam—Discomfort—Metformin—polycystic ovary syndrome	0.00654	0.00871	CcSEcCtD
Alprazolam—Oedema—Metformin—polycystic ovary syndrome	0.00635	0.00845	CcSEcCtD
Alprazolam—Infection—Metformin—polycystic ovary syndrome	0.00631	0.0084	CcSEcCtD
Alprazolam—Shock—Metformin—polycystic ovary syndrome	0.00625	0.00832	CcSEcCtD
Alprazolam—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00623	0.00829	CcSEcCtD
Alprazolam—Skin disorder—Metformin—polycystic ovary syndrome	0.00617	0.00821	CcSEcCtD
Alprazolam—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00614	0.00817	CcSEcCtD
Alprazolam—Anorexia—Metformin—polycystic ovary syndrome	0.00605	0.00806	CcSEcCtD
Alprazolam—Hypotension—Metformin—polycystic ovary syndrome	0.00593	0.0079	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00579	0.0077	CcSEcCtD
Alprazolam—Paraesthesia—Metformin—polycystic ovary syndrome	0.0057	0.00759	CcSEcCtD
Alprazolam—Dyspnoea—Metformin—polycystic ovary syndrome	0.00566	0.00754	CcSEcCtD
Alprazolam—Somnolence—Metformin—polycystic ovary syndrome	0.00565	0.00751	CcSEcCtD
Alprazolam—Dyspepsia—Metformin—polycystic ovary syndrome	0.00559	0.00744	CcSEcCtD
Alprazolam—Decreased appetite—Metformin—polycystic ovary syndrome	0.00552	0.00735	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00548	0.0073	CcSEcCtD
Alprazolam—Fatigue—Metformin—polycystic ovary syndrome	0.00547	0.00729	CcSEcCtD
Alprazolam—Constipation—Metformin—polycystic ovary syndrome	0.00543	0.00723	CcSEcCtD
Alprazolam—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00523	0.00697	CcSEcCtD
Alprazolam—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00519	0.00691	CcSEcCtD
Alprazolam—Urticaria—Metformin—polycystic ovary syndrome	0.00504	0.00671	CcSEcCtD
Alprazolam—Abdominal pain—Metformin—polycystic ovary syndrome	0.00502	0.00668	CcSEcCtD
Alprazolam—Asthenia—Metformin—polycystic ovary syndrome	0.00456	0.00606	CcSEcCtD
Alprazolam—Pruritus—Metformin—polycystic ovary syndrome	0.00449	0.00598	CcSEcCtD
Alprazolam—Diarrhoea—Metformin—polycystic ovary syndrome	0.00434	0.00578	CcSEcCtD
Alprazolam—Dizziness—Metformin—polycystic ovary syndrome	0.0042	0.00559	CcSEcCtD
Alprazolam—Vomiting—Metformin—polycystic ovary syndrome	0.00404	0.00537	CcSEcCtD
Alprazolam—Rash—Metformin—polycystic ovary syndrome	0.004	0.00533	CcSEcCtD
Alprazolam—Dermatitis—Metformin—polycystic ovary syndrome	0.004	0.00532	CcSEcCtD
Alprazolam—Headache—Metformin—polycystic ovary syndrome	0.00398	0.0053	CcSEcCtD
Alprazolam—Nausea—Metformin—polycystic ovary syndrome	0.00377	0.00502	CcSEcCtD
Alprazolam—Loxapine—ADRA1B—polycystic ovary syndrome	0.00232	0.0315	CrCbGaD
Alprazolam—Loxapine—ADRA1A—polycystic ovary syndrome	0.00156	0.0212	CrCbGaD
Alprazolam—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000415	0.00237	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—IRS2—polycystic ovary syndrome	0.000413	0.00236	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—DLG4—polycystic ovary syndrome	0.000403	0.0023	CbGpPWpGaD
Alprazolam—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000399	0.00228	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—DLG4—polycystic ovary syndrome	0.000396	0.00226	CbGpPWpGaD
Alprazolam—CYP3A7—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000396	0.00226	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000393	0.00225	CbGpPWpGaD
Alprazolam—CYP3A7—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000391	0.00223	CbGpPWpGaD
Alprazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000391	0.00223	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—DLG4—polycystic ovary syndrome	0.000389	0.00222	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000389	0.00222	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—DLG4—polycystic ovary syndrome	0.000387	0.00221	CbGpPWpGaD
Alprazolam—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000385	0.0022	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000384	0.00219	CbGpPWpGaD
Alprazolam—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000382	0.00218	CbGpPWpGaD
Alprazolam—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00038	0.00217	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—DLG4—polycystic ovary syndrome	0.00038	0.00217	CbGpPWpGaD
Alprazolam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000378	0.00216	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000375	0.00215	CbGpPWpGaD
Alprazolam—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000373	0.00213	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000366	0.00209	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000362	0.00207	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000362	0.00207	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—IRS1—polycystic ovary syndrome	0.000361	0.00206	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000357	0.00204	CbGpPWpGaD
Alprazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000341	0.00195	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—DLG4—polycystic ovary syndrome	0.000332	0.0019	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000332	0.0019	CbGpPWpGaD
Alprazolam—CYP3A5—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000324	0.00185	CbGpPWpGaD
Alprazolam—CYP3A7—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000319	0.00182	CbGpPWpGaD
Alprazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000317	0.00181	CbGpPWpGaD
Alprazolam—CYP3A7—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000315	0.0018	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00031	0.00177	CbGpPWpGaD
Alprazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000309	0.00177	CbGpPWpGaD
Alprazolam—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000308	0.00176	CbGpPWpGaD
Alprazolam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000306	0.00175	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000305	0.00174	CbGpPWpGaD
Alprazolam—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000305	0.00174	CbGpPWpGaD
Alprazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000297	0.00169	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000294	0.00168	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000286	0.00164	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000282	0.00161	CbGpPWpGaD
Alprazolam—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000282	0.00161	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NMNAT3—polycystic ovary syndrome	0.000281	0.0016	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000274	0.00157	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000271	0.00155	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—LPCAT2—polycystic ovary syndrome	0.000257	0.00147	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SUOX—polycystic ovary syndrome	0.000257	0.00147	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000255	0.00146	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000255	0.00146	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000251	0.00144	CbGpPWpGaD
Alprazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000251	0.00143	CbGpPWpGaD
Alprazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000249	0.00142	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000246	0.00141	CbGpPWpGaD
Alprazolam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000246	0.0014	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000239	0.00137	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ISYNA1—polycystic ovary syndrome	0.000239	0.00136	CbGpPWpGaD
Alprazolam—CYP3A7—Biological oxidations—POMC—polycystic ovary syndrome	0.000238	0.00136	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000235	0.00134	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000232	0.00133	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000232	0.00133	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000231	0.00132	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000231	0.00132	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000229	0.00131	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000229	0.00131	CbGpPWpGaD
Alprazolam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000228	0.0013	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000228	0.0013	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000225	0.00129	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000222	0.00127	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000219	0.00125	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000218	0.00125	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000214	0.00123	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000213	0.00122	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000209	0.0012	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000209	0.0012	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000204	0.00117	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000203	0.00116	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—AKR1C2—polycystic ovary syndrome	0.000203	0.00116	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—TEAD2—polycystic ovary syndrome	0.000203	0.00116	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NMNAT3—polycystic ovary syndrome	0.000203	0.00116	CbGpPWpGaD
Alprazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000202	0.00115	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000202	0.00115	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000201	0.00115	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.0002	0.00114	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000199	0.00114	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000197	0.00112	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000196	0.00112	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000195	0.00111	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000195	0.00111	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000191	0.00109	CbGpPWpGaD
Alprazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000186	0.00106	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—LPCAT2—polycystic ovary syndrome	0.000186	0.00106	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SUOX—polycystic ovary syndrome	0.000186	0.00106	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000185	0.00105	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000183	0.00104	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000181	0.00103	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000178	0.00102	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000176	0.00101	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000176	0.001	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000176	0.001	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ISYNA1—polycystic ovary syndrome	0.000173	0.000986	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—POMC—polycystic ovary syndrome	0.000172	0.000983	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000171	0.000975	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PNPLA2—polycystic ovary syndrome	0.00017	0.000972	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000168	0.000963	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000168	0.000961	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000167	0.000957	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000167	0.000956	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000166	0.000948	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000165	0.00094	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000164	0.000934	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000163	0.000929	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SRD5A1—polycystic ovary syndrome	0.000161	0.000921	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000161	0.000918	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00016	0.000917	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—STAR—polycystic ovary syndrome	0.000154	0.000879	CbGpPWpGaD
Alprazolam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000151	0.00086	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00015	0.000855	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—TEAD2—polycystic ovary syndrome	0.000147	0.000838	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—AKR1C2—polycystic ovary syndrome	0.000147	0.000838	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000143	0.000818	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.00014	0.000802	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—HMMR—polycystic ovary syndrome	0.000137	0.000783	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000136	0.00078	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000133	0.000762	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000133	0.00076	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000131	0.00075	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000131	0.000748	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000131	0.000748	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—HSD3B1—polycystic ovary syndrome	0.000131	0.000747	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000129	0.000738	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PNPLA2—polycystic ovary syndrome	0.000123	0.000703	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000122	0.000695	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000122	0.000695	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000121	0.000693	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—LHB—polycystic ovary syndrome	0.000119	0.000682	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000119	0.000679	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—HSD3B2—polycystic ovary syndrome	0.000117	0.000666	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SRD5A1—polycystic ovary syndrome	0.000117	0.000666	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—AKR1C1—polycystic ovary syndrome	0.000113	0.000645	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	0.000111	0.000635	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000111	0.000634	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000107	0.000613	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000106	0.000605	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000105	0.000602	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SULT2A1—polycystic ovary syndrome	0.000104	0.000594	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000103	0.000591	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000103	0.000591	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—RRM2—polycystic ovary syndrome	0.000101	0.000575	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	9.95e-05	0.000568	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	9.91e-05	0.000566	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	9.79e-05	0.000559	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—YAP1—polycystic ovary syndrome	9.7e-05	0.000554	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	9.46e-05	0.00054	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	9.44e-05	0.000539	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NAMPT—polycystic ovary syndrome	9.32e-05	0.000533	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP11A1—polycystic ovary syndrome	9.2e-05	0.000526	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—AKR1C3—polycystic ovary syndrome	8.69e-05	0.000497	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	8.67e-05	0.000495	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	8.63e-05	0.000493	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	8.63e-05	0.000493	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	8.62e-05	0.000493	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP17A1—polycystic ovary syndrome	8.56e-05	0.000489	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	8.43e-05	0.000482	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	8.22e-05	0.00047	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	8.16e-05	0.000466	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	8.02e-05	0.000458	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	8e-05	0.000457	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	7.84e-05	0.000448	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	7.75e-05	0.000443	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	7.51e-05	0.000429	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—TH—polycystic ovary syndrome	7.4e-05	0.000423	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	7.27e-05	0.000416	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SLC2A4—polycystic ovary syndrome	7.2e-05	0.000412	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	7.01e-05	0.000401	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	6.99e-05	0.000399	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	6.82e-05	0.00039	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	6.82e-05	0.00039	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP19A1—polycystic ovary syndrome	6.77e-05	0.000387	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	6.74e-05	0.000385	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	6.67e-05	0.000381	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	6.65e-05	0.00038	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.59e-05	0.000376	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	6.28e-05	0.000359	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.25e-05	0.000357	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	6.19e-05	0.000353	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	6.08e-05	0.000347	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	6.04e-05	0.000345	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	5.94e-05	0.000339	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	5.76e-05	0.000329	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	5.75e-05	0.000329	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	5.72e-05	0.000327	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	5.46e-05	0.000312	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	5.42e-05	0.00031	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—TH—polycystic ovary syndrome	5.35e-05	0.000306	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	5.3e-05	0.000303	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	5.21e-05	0.000298	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	5.17e-05	0.000295	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	5.13e-05	0.000293	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	5.09e-05	0.000291	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	4.94e-05	0.000282	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	4.9e-05	0.00028	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	4.75e-05	0.000271	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.72e-05	0.00027	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	4.69e-05	0.000268	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.66e-05	0.000266	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	4.61e-05	0.000263	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	4.43e-05	0.000253	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	4.4e-05	0.000251	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	4.37e-05	0.00025	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	4.36e-05	0.000249	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	4.16e-05	0.000238	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	4.13e-05	0.000236	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	4.07e-05	0.000233	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—INS—polycystic ovary syndrome	4.05e-05	0.000231	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	4.01e-05	0.000229	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	3.95e-05	0.000225	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	3.92e-05	0.000224	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	3.79e-05	0.000217	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—TH—polycystic ovary syndrome	3.77e-05	0.000216	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	3.68e-05	0.00021	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	3.67e-05	0.00021	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	3.49e-05	0.0002	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	3.45e-05	0.000197	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.38e-05	0.000193	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.26e-05	0.000186	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	3.13e-05	0.000179	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.09e-05	0.000177	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	3.08e-05	0.000176	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	2.98e-05	0.00017	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	2.94e-05	0.000168	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	2.93e-05	0.000168	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—INS—polycystic ovary syndrome	2.93e-05	0.000167	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	2.92e-05	0.000167	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.88e-05	0.000164	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	2.78e-05	0.000159	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	2.59e-05	0.000148	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.49e-05	0.000142	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.42e-05	0.000138	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.28e-05	0.00013	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	2.1e-05	0.00012	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	2.07e-05	0.000119	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—INS—polycystic ovary syndrome	2.06e-05	0.000118	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.03e-05	0.000116	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.94e-05	0.000111	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.83e-05	0.000105	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.71e-05	9.77e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.39e-05	7.92e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.37e-05	7.82e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.36e-05	7.77e-05	CbGpPWpGaD
